Bladder cancer decisions — 2023

The Veteran's left renal pelvic carcinoma with bladder cancer remains active and malignant, meeting the criteria for a 100% evaluation effective July 1, 2020.

The Board has remanded the claim of service connection for bladder cancer due to in-service asbestos exposure, as it requires additional development and an opinion from a VA examiner.

The Veteran's bladder cancer is presumed to be due to exposure to herbicide agents during service, specifically while maintaining C-123 aircraft. The Board granted service connection for the condition based on this presumption.

Your bladder cancer has been granted service connection, so the appeal is dismissed as moot.

The Board has remanded the claims for rectal cancer and liver cancer due to exposure at Camp Lejeune, but denied an earlier effective date for bladder cancer.

The Veteran's bladder cancer residuals are rated at 40 percent, effective December 1, 2021. The appeal for an earlier effective date for DIC benefits is denied.

The Veteran's bladder cancer residuals with hydronephrosis are rated at 60 percent effective August 28, 2018.

The Veteran's prostate and bladder cancers were granted a 100% rating effective October 19, 2022. The earlier claim for increased rating is granted.

The Board has determined that new evidence was received and warrants a readjudication of the Veteran's claim for service connection for bladder cancer. The case is now remanded to provide an examination and obtain a medical opinion regarding the etiology of the Veteran's bladder cancer.

The Board has denied the Veteran's claims for service connection for bladder cancer and ischemic heart disease, finding that there is no evidence of herbicide exposure or service in Vietnam. The disabilities were not shown to be related to service.

The Board has determined that the Veteran's bladder cancer is not related to service, specifically his exposure to herbicide agents or asbestos. The evidence does not support a finding of service connection for either issue.

The Board has determined that additional development is necessary for the Veteran's claims of service connection for bilateral hearing loss and bladder cancer. The claims are being remanded to allow for further examination and opinion.

Your claim for service connection for bladder cancer has been fully granted, and the Board is dismissing your appeal as moot.

The Board denied service connection for bladder cancer, kidney cancer, liver cancer, hepatic steatosis, and a kidney condition to include renal failure and resolved rhabdomyolysis due to lack of current diagnoses.,The Veteran served at Camp Lejeune during the period from June 1971 to May 1972. He was presumed exposed to contaminated water at Camp Lejeune.

Your claim for service connection for bladder cancer has been granted, effective March 6, 2018. The appeal is dismissed as the issue has been resolved in your favor.

The Board has remanded the Veteran's claims for service connection due to incomplete compliance with previous remand directives regarding radiation exposure. The case is being returned to the Jackson Regional Office for further action.

The Board has determined that further examination and opinion are needed to clarify the cause of the Veteran's death, including whether it was related to his service-connected bladder cancer or to his alleged exposures at Camp Lejeune and in Vietnam.

The Veteran's claims for service connection for bladder cancer and kidney cancer are denied as there is no evidence of these conditions during or within one year after his military service, and the exposure basis provided (Camp Lejeune) does not apply to him.

The Veteran's claim for service connection for bladder cancer was denied in a previous decision, but the claim has since been granted by the AOJ. The appeal is dismissed as there is no longer a case or controversy to resolve.

The Board has remanded the case due to insufficient medical opinion regarding the relationship between the Veteran's service-connected conditions and his death.